| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.56B | 4.25B | 4.49B | 5.80B | 5.05B | 4.64B |
| Gross Profit | 1.31B | 1.58B | 1.91B | 2.39B | 2.19B | 2.07B |
| EBITDA | 208.40M | 737.40M | 786.20M | 1.30B | 1.19B | 1.04B |
| Net Income | -534.90M | 339.90M | 1.32B | 736.50M | 739.60M | 552.40M |
Balance Sheet | ||||||
| Total Assets | 12.08B | 11.65B | 11.93B | 11.17B | 10.58B | 10.19B |
| Cash, Cash Equivalents and Short-Term Investments | 497.70M | 357.30M | 302.40M | 572.00M | 516.80M | 568.90M |
| Total Debt | 1.27B | 3.50B | 4.11B | 3.27B | 3.17B | 3.27B |
| Total Liabilities | 8.28B | 7.14B | 7.49B | 7.77B | 7.53B | 7.20B |
| Stockholders Equity | 3.77B | 4.49B | 4.41B | 3.40B | 3.05B | 2.98B |
Cash Flow | ||||||
| Free Cash Flow | -285.40M | 603.20M | -520.30M | 440.10M | 720.00M | 580.60M |
| Operating Cash Flow | -263.80M | 671.10M | -386.40M | 582.40M | 820.10M | 647.80M |
| Investing Cash Flow | 375.80M | 263.60M | -154.40M | -266.40M | -112.00M | -169.30M |
| Financing Cash Flow | -483.00M | -870.10M | 331.50M | -237.40M | -747.90M | -250.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $13.78B | 10.25 | 27.46% | 2.45% | 12.59% | 31.40% | |
65 Neutral | $8.32B | 6.80 | 10.00% | 3.40% | 3.82% | 239.39% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | $8.51B | 23.17 | 6.24% | 3.24% | -1.22% | -14.31% | |
50 Neutral | $3.23B | 22.65 | ― | 4.71% | -3.93% | ― | |
48 Neutral | $1.68B | ― | -11.52% | 17.89% | -13.42% | -136.59% | |
28 Underperform | $342.34M | -0.18 | ― | ― | ― | 42.75% |
FMC Corp’s recent earnings call painted a mixed picture, highlighting both positive developments and significant challenges. The sentiment was balanced, with optimism stemming from strong demand for new active ingredients and improved EBITDA, contrasted by concerns over a sharp revenue decline, particularly in Latin America, and a substantial dividend cut to address cash flow issues.
FMC Corp faces potential business risks as outlined in their Form 10-Q and Form 10-K filings, which stakeholders should review carefully. These documents, accessible via the SEC and the company’s website, detail various risk factors that could impact FMC Corp’s operations and financial performance. Investors and analysts are advised to consider these risks in conjunction with other market conditions when evaluating the company’s future prospects. The comprehensive risk assessments provided in these reports are crucial for understanding the challenges FMC Corp may encounter in the coming months.
FMC Corporation is a global agricultural sciences company focused on providing innovative crop protection solutions, including biologicals, crop nutrition, and digital agriculture, to help growers address challenges while protecting the environment.
On October 29, 2025, FMC Corporation announced that Ronaldo Pereira will step down as President effective December 15, 2025, after 28 years with the company. Pereira, a veteran in the crop protection industry, has significantly impacted FMC’s operations in Latin America and North America. He will remain in an advisory role until his departure to ensure a smooth transition.
The most recent analyst rating on (FMC) stock is a Buy with a $43.00 price target. To see the full list of analyst forecasts on FMC stock, see the FMC Stock Forecast page.